Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

People distressed by minor skin changes should consult dermatologists with cosmetic expertise, and a public Cosmetic Dermatology Service with mental health support is recommended.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Pica disorder in central Iraq is mainly found in females and is linked to low iron levels; treatment with iron improves most patients.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

Pregnancy can cause specific skin conditions that need correct diagnosis and treatment to protect both mother and baby.

Male rats grow hair faster than females, and certain hormones can slow or slightly increase hair growth, but not significantly beyond natural rates.

Men with advanced liver disease and high oestrone and low testosterone levels have worse health outcomes.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

A woman with Kallman's syndrome also developed alopecia universalis, a condition not previously linked to Kallman's.

Non-daily contraceptives cause fewer side effects and are more satisfying to women, and certain oral contraceptives can treat acne and seborrhoea, with a combination of chlormadinone acetate and ethinyl estradiol being highly effective and safe.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

The document says that early treatment of Acne Vulgaris is important to prevent scarring and that adult onset acne is common in women, often due to hormonal imbalances.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Pregnancy with Cushing's syndrome is rare and risky for both mother and baby, needing early diagnosis and treatment.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.